Eriksson, J. A., Wanka, C., Burger, M. C., Urban, H., Hartel, I., von Renesse, J., . . . Rieger, J. (2018). Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma. Journal of Neurochemistry, 144(4), 421. https://doi.org/10.1111/jnc.14264
Chicago Style (17th ed.) CitationEriksson, Jule A., et al. "Suppression of Oxidative Phosphorylation Confers Resistance Against Bevacizumab in Experimental Glioma." Journal of Neurochemistry 144, no. 4 (2018): 421. https://doi.org/10.1111/jnc.14264.
MLA (9th ed.) CitationEriksson, Jule A., et al. "Suppression of Oxidative Phosphorylation Confers Resistance Against Bevacizumab in Experimental Glioma." Journal of Neurochemistry, vol. 144, no. 4, 2018, p. 421, https://doi.org/10.1111/jnc.14264.